Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124662102 | 12466210 | 2 | F | 201603 | 20160725 | 20160614 | 20160729 | EXP | US-BIOGEN-2016BI00250407 | BIOGEN | 50.69 | YR | F | Y | 0.00000 | 20160729 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124662102 | 12466210 | 1 | PS | TYSABRI | NATALIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125104 | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||||
124662102 | 12466210 | 2 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 3 | C | SUMATRIPTAN. | SUMATRIPTAN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 4 | C | NEURONTIN | GABAPENTIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 5 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 6 | C | LASIX | FUROSEMIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 7 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 8 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 9 | C | VALIUM | DIAZEPAM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 10 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 11 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 12 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 13 | C | LIPODERM | BACLOFENCYCLOBENZAPRINEDICLOFENACGABAPENTINTETRACAINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
124662102 | 12466210 | 14 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124662102 | 12466210 | 1 | Multiple sclerosis |
124662102 | 12466210 | 2 | Product used for unknown indication |
124662102 | 12466210 | 3 | Product used for unknown indication |
124662102 | 12466210 | 4 | Product used for unknown indication |
124662102 | 12466210 | 5 | Product used for unknown indication |
124662102 | 12466210 | 6 | Product used for unknown indication |
124662102 | 12466210 | 7 | Product used for unknown indication |
124662102 | 12466210 | 8 | Product used for unknown indication |
124662102 | 12466210 | 9 | Product used for unknown indication |
124662102 | 12466210 | 10 | Product used for unknown indication |
124662102 | 12466210 | 11 | Product used for unknown indication |
124662102 | 12466210 | 12 | Product used for unknown indication |
124662102 | 12466210 | 13 | Product used for unknown indication |
124662102 | 12466210 | 14 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124662102 | 12466210 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124662102 | 12466210 | Drug ineffective | |
124662102 | 12466210 | Gait disturbance | |
124662102 | 12466210 | Migraine | |
124662102 | 12466210 | Mobility decreased | |
124662102 | 12466210 | Suicidal ideation | |
124662102 | 12466210 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124662102 | 12466210 | 1 | 20120412 | 0 |